Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07891650) titled 'Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Related to Cerebral Small Vessel Disease' on Oct. 18.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Xuanwu Hospital, Beijing
Condition:
Cerebral Small Vessel Disease
Vascular Cognitive Impairment
Intervention:
Device: Active Personalized Intermittent Theta Burst Stimulation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 2026
Target Sample Size: 16...